| Patents for C07D 315 - Heterocyclic compounds containing rings having one oxygen atom as the only ring hetero atom according to more than one of groups (1,360) |
|---|
| 01/08/2009 | US20090010880 2-Amino-2,7-dideoxy-alpha-D-glycero-D-gluco-heptopyranosyl Inhibitors of Positive Sense Single-Stranded RNA Envelope Viruses |
| 12/04/2008 | US20080299390 Moulded Catalyst Bodies and Method for Hydrogenation of Carbonyl Compounds |
| 12/03/2008 | CN100439349C Liquid phase oxidation reaction using compound containing tungsten |
| 12/02/2008 | US7459571 Low cost, impact and chemical resistant, shaped bodies; high conversion rate and selectivity; such as maleic anhydride to tetrahydrofuran and gamma-butyrolactone |
| 11/20/2008 | US20080287529 Crystal structures of sglt2 inhibitors and processes for preparing same |
| 11/06/2008 | US20080275230 Polymers having covalently bound antibiotic agents |
| 10/23/2008 | US20080260774 Activation cytokine response in immune system including lymphocyte and antigen; anticancer agents; infection diseases; autoimmune disease; vaccine |
| 10/21/2008 | US7439352 Process for the production of anhydrosugar alcohols |
| 10/08/2008 | EP1673363B1 Method for producing 1-hydroperoxy-16-oxabicyclo [10.4.0]hexadecane |
| 09/25/2008 | DE112006002818T5 Verfahren zur Herstellung von (10/11/12)-Pentadecen-15-olid ausgehend von 11- und/oder 12-Pendatecen-15-olid A process for the preparation of (10/11/12) -pentadecen-15-olide starting from 11- and / or 12-Pendatecen-15-olide |
| 09/18/2008 | US20080226716 Gamma aminobutyric acid antagonist such as naphthylalanine; antiepileptic agents; antidepressants; anxiolytic agents; psychological disorders; neurodegenerative diseases; analgesics; drug withdrawal |
| 09/16/2008 | US7425519 Liquid phase oxygenation reaction using tungsten species |
| 09/04/2008 | US20080214845 N-Protected Paromomycin; low molecular weight orally-bioavailable drugs that work by binding to RNA |
| 08/26/2008 | US7417059 Substituted aromatic-ring compounds, process for producing the same and use |
| 08/14/2008 | US20080194650 Aryl fluoroethyl ureas acting as alpha 2 adrenergic agents |
| 08/13/2008 | EP1473291B1 Process for producing lactone |
| 08/07/2008 | US20080188552 Crystalline form of sodium pravastatin produced from amine salt; high purity and yield; antihypercholesterolemic agents; low raw material cost |
| 07/24/2008 | US20080176936 e.g. 1,4-hydroxy-2(3aminophenyl)amide-3(4bromobenzyl)-5(carboxymethyl-oxymethyl)pyran; integrin receptor antagonist; antiproliferative, anticarcinogenic, antiinflammatory, antidiabetic agent; improved bioavailability |
| 07/23/2008 | CN100404544C 9-ketospinosyn derivatives |
| 07/17/2008 | US20080171863 Reacting fluorine salt containing radioactive fluorine-18 with alkyl halide or alkyl sulfonate in presence of alcohol; decreased reaction time; high yield; reduces the formation of side products |
| 07/10/2008 | WO2008081568A1 Novel macrolide compound |
| 07/10/2008 | WO2008026140A3 Malodor counteracting compositions and method for their use |
| 07/10/2008 | US20080163790 Dispersants |
| 07/09/2008 | CN100400533C Valerolactone compounds and perfume composition |
| 06/25/2008 | CN101205225A Method for preparing lactones by biomimetic catalytic oxidation of ketone compounds |
| 06/19/2008 | US20080146642 Propanesulfonic acid amino acid prodrugs that can deliver 3-amino-1-propanesulfonic acid (3APS) by minimizing metabolism associated with that drug, particularly compounds that block or protect amino group of 3APS such that it avoids metabolism by transaminases or monoamine oxidase; Alzheimer's disease |
| 06/05/2008 | US20080127857 Dispersants |
| 05/21/2008 | EP1601660B1 Process for the preparation of lactones or epoxides |
| 05/08/2008 | US20080108826 Using 4-alkoxytetrahydropyrane derivatives; 1-benzoyl-3-[2-methoxy-5-(tetrahydropyran-4-yl)-phenyl]-thiourea; used in preparation of adenosine receptor ligands |
| 05/08/2008 | US20080108694 Inhibit the growth of or kill Rb negative cancer cells; inhibit the activity of Heat shock protein 90; antibiotics, antimalarial agents, anticancer agents, antitumor agents; cytotoxicity; to treat glioblastoma, lung cancer and retinoblastoma |
| 05/06/2008 | US7368572 Anticancer agents |
| 04/29/2008 | US7365215 Process for preparing 4-aminotetrahydropyran compound and an acid salt thereof, synthetic intermediate thereof and process for preparing the same |
| 04/24/2008 | WO2008046790A1 Method for producing lactones from diols |
| 04/16/2008 | CN101163656A Catalysts for maleic acid hydrogenation to 1,4-butanediol |
| 04/16/2008 | CN101161649A Method for synthesizing lactone compound by catalytic oxidation of cyclone |
| 03/26/2008 | CN100376564C Substituted heterocyclic benzoeycloalkenes and the use thereof as substances having analgesic effect |
| 03/13/2008 | US20080064883 Low cost, impact and chemical resistant, shaped bodies; high conversion rate and selectivity; such as maleic anhydride to tetrahydrofuran and gamma-butyrolactone |
| 03/06/2008 | WO2008026140A2 Malodor counteracting compositions and method for their use |
| 03/06/2008 | US20080058383 Such as 2-methyl-2-(4-nitro-3-trifluoromethyl-phenylamino)-propan-1-ol; prostate cancer; cardiovascular disorders; psychological disorders |
| 02/28/2008 | US20080051575 capable of switching between the two states in response to at least actinic radiation; thermally reversible |
| 02/21/2008 | WO2008020830A1 Method of treating an aspergillus or cryptococcus infection by administering ambruticin vs-3, vs-4, or vs-5 |
| 02/21/2008 | US20080045704 Photochromic compounds |
| 02/20/2008 | EP1055654B1 Process for the preparation of organic compounds with imide catalysts |
| 02/12/2008 | US7329330 Divided wall structure; rectifier and stripping zone |
| 01/31/2008 | US20080027096 Novel Pharmaceutical Compositions |
| 01/31/2008 | US20080026943 Phenyl-Substituted [1,2]-Oxazine-3,5-Dione and Dihydropyrone Derivatives |
| 01/30/2008 | CN100364950C Process for preparing 2-(alkyl) cyclic ketone |
| 01/23/2008 | CN100363360C Preparation method of e-caprolactone |
| 01/10/2008 | US20080009545 Anticancer agents |
| 01/03/2008 | US20080004440 Scar treatment using protein phosphatase inhibitors |
| 01/03/2008 | US20080004415 Non-linear optically active molecules, their synthesis, and use |
| 01/01/2008 | US7314943 2,5-disubstitution; enyne metathesis cyclization preparation; aroma substances or intermediates |
| 12/27/2007 | WO2007149543A2 Scar treatment using protein phosphatase inhibitors |
| 12/27/2007 | US20070299065 Tetrahydropyran Derivatives as Antidiabetics |
| 12/25/2007 | US7312200 9-ketospinosyn derivatives |
| 12/19/2007 | CN100355741C Process for simultaneous production of maleic anlydride and its hydrogenated derivatives |
| 12/13/2007 | US20070287745 Laulimalide Analogs and Uses Thereof |
| 12/13/2007 | US20070287731 1-Benzyl-3-[3-(3,5-dimethyl-phenyl)-5,5-dimethyl-[1,2,4]oxadiazol-4-yl]-urea; nuclear receptor-based inducible gene expression system |
| 12/12/2007 | EP1305022B1 Processes for the purification of tocopherol and/or sterol compounds and compositions containing orthoborate ester mixtures |
| 12/05/2007 | CN101084210A Process |
| 11/29/2007 | US20070276144 Synthesis Of Discodermolide And Variants Thereof |
| 11/29/2007 | US20070274911 Production of 2-18F-2-Deoxy-D-Glucose Via Solid-Phase Synthesis |
| 11/22/2007 | US20070270485 Byrostatin analogues, synthetic methods and uses |
| 11/08/2007 | US20070258905 Contrast Agents Endowed with High Relaxivity for Use in Magnetic Resonance Imaging (Mri) Which Contain a Chelating Moiety with Polyhydroxylated Substituents |
| 11/08/2007 | US20070258890 Anthracycline Derivatives |
| 11/06/2007 | US7291367 Liquid-crystalline compounds |
| 10/30/2007 | US7288680 Benzotropolone derivatives and modulation of inflammatory response |
| 10/25/2007 | US20070249687 Antivirals; anti-HIV drugs with other mechanism of action to prevent cross-resistance |
| 10/25/2007 | US20070248586 Oxylipins from stearidonic acid and gamma-linolenic acid and methods of making and using the same |
| 10/18/2007 | US20070244328 Organocatalysts and Methods of Use in Chemical Synthesis |
| 10/11/2007 | US20070238871 Glycolipids And Analogues Thereof As Antigens For NKT Cells |
| 10/04/2007 | US20070232719 1,1-Disubstituted 2-vinylcyclopropanes; free radical polymerizable monomers; dental materials, in particular as dental adhesives, fixing cements or filling composites; low polymerization shrinkage, good mechanical properties |
| 10/02/2007 | CA2330756C Indole derivatives and their use for the treatment of malignant and other diseases based on pathological cell proliferation |
| 09/20/2007 | US20070219382 chemical synthesis; catalytic preparation for (2R)-2-{[(4-Fluoro-3-methylphenyl)sulfonyl]amino}-N-hydroxy-2(tetrahydro-2H-pyran-4-yl)acetamide; make potent lethal factor (LF) inhibitors for the treatment of anthrax; bactericides |
| 09/04/2007 | US7265230 Herbicides |
| 08/23/2007 | US20070197587 Quinoline Derivatives as CRTH2 Antagonists |
| 08/21/2007 | USRE39794 Vapour phase oxidation of hydrocarbons in the presence of oxidation catalysts to form chemical intermediates for 1,4-butanediol, G-butyrolactone and tetrahydrofuran; efficiency |
| 08/16/2007 | WO2006046140A3 Process for the preparation of lactones |
| 08/15/2007 | EP1817298A2 Process for the preparation of lactones |
| 08/01/2007 | EP1812363A1 Selective oxidation of organic compounds |
| 08/01/2007 | CN1329385C Process for prodn. of tetrahydrofuran and gamma-butyrolactone |
| 08/01/2007 | CN1329120C Catalyst coating for hydrogenation of maleic anhyride and related compounds |
| 07/18/2007 | CN1326611C Supported catalyst containing rhenium and method for hydrogenation of carbonyl compounds in liquid phase by means of said catalyst |
| 07/10/2007 | CA2283564C Pharmaceutical compositions having appetite suppressant activity |
| 07/04/2007 | CN1993363A 1,3-disubstituted heteroaryl nmda/nr2b antagonists |
| 06/26/2007 | US7235351 Squalirium compound, thermally developable photographic material containing said compound, and image forming method thereof |
| 06/21/2007 | US20070142679 Hydrogenation of dicarboxylic acids to form diols, cyclic ethers and lactones in the presence of an aqueous solution of a ruthenium, rhodium, iron, osmium or palladium compound and a phosphine, preferably tridentate facially capped phosphines (tris-1,1,1-(diarylphosphinomethyl)alkane) |
| 06/20/2007 | EP1797094A2 1,3-disubstituted heteroaryl nmda/nr2b antagonists |
| 06/12/2007 | US7230125 Methods of performing cycloadditions, reaction mixtures, and methods of performing asymmetric catalytic reactions |
| 06/07/2007 | US20070129260 Comprising 4-chloro-4-deoxygalactose or a derivative thereof or 1,6-dichloro-1,6-dideoxyfructose as well fluid additives for use in a subterranean formation that includes a chlorinated carbohydrate and a tartaric acid |
| 05/29/2007 | CA2373927C Improved process for the preparation of 3,4-dihydroxybutanoic acid and salts and lactones derived therefrom |
| 05/24/2007 | US20070117719 Low cost, impact and chemical resistant, shaped bodies; high conversion rate and selectivity; Al2O3 as catalyst support material; hydrogenation catalyst for converting maleic anhydride to tetrahydrofuran and gamma-butyrolactone |
| 05/22/2007 | US7220760 1-carbonyl-4-carbonylaminotetrahydroquinoline derivatives; especially treating asthma and allergic rhinitis |
| 05/18/2007 | WO2007054429A1 Process for the production of (10/11/12)-pentadecen-15-olide starting from 11- and/or 12-pentadecen-15-olide |
| 05/16/2007 | CN1964783A Catalyst extrudates based on copper oxide and their use for hydrogenating carbonyl compounds |
| 05/15/2007 | US7217679 Catalytic coating for the hydrogenation of maleic anhydride and related compounds to give γ-butyrolactone, tetrahydrofuran and derivatives thereof |
| 05/08/2007 | US7214641 Catalyst and hydrogenation of carbonyl compounds in the liquid phase using the catalyst |
| 05/02/2007 | CN1956992A Anthracycline derivatives |
| 04/18/2007 | EP1773746A1 Catalysts for maleic acid hydrogenation to 1,4-butanediol |
| 04/18/2007 | CN1950354A Process for making n-sulfonated-amino acid derivatives |